da Silva AMP, Januario Campos Cardoso L, Batista S, Goncalves OR, et al. Tirzepatide versus semaglutide for the prevention of mild cognitive impairment, dementia, and Alzheimer's disease in type 2 diabetes: A real-world, retrospective cohort study. J Diabetes Complications 2026;40:109306.
PMID: 41825212